Propofol注射液市場：依產品類型、應用、劑型、最終用戶、通路及地區分類

預計到2026年，Propofol注射劑市值將達17.7億美元，2033年將達33.5億美元。預計從2026年到2033年，其複合年成長率將達到9.5%。

全球Propofol注射劑市場是製藥業的重要組成部分，涵蓋了現代醫療實踐中最廣泛使用的靜脈麻醉劑之一。Propofol（化學名稱：2,6-二異丙基苯酚）是一種短效鎮靜催眠藥，主要用於全身麻醉的誘導和維持，以及加護病房和治療室的鎮靜。這種注射藥物因其起效迅速、易於控制鎮靜深度、殘留效應小和恢復快等優點，徹底改變了全球麻醉方式。

該市場涵蓋各種濃度和配方的Propofol注射劑，以滿足包括外科手術、診斷程序和重症監護管理在內的多種醫療應用需求。醫院、門診手術中心和專科診所是推動市場需求的主要終端使用者。外科手術量的增加、需要醫療干預的老年人口的成長以及門診手術設施的擴建，都顯著促進了市場成長。此外，新興市場對Propofol的日益普及，以及持續不斷的配方改進研發工作，已使該市場成為全球麻醉劑行業的重要組成部分。

市場動態

全球Propofol注射液市場受多種強烈市場促進因素的影響。其中最重要的是全球外科手術數量的快速成長，這主要歸因於人口老化導致各種醫療干預需求增加，涵蓋從常規手術到複雜手術的各個方面。此外，需要手術治療的慢性疾病盛行率不斷上升，新興經濟體醫療保健支出的增加和醫療基礎設施的改善也顯著推動了市場需求。Propofol因其優異的藥物動力學特性（包括起效和恢復迅速、副作用極小以及患者耐受性良好）而優於傳統麻醉劑，這些優勢促使其在醫療機構中得到廣泛應用。然而，該市場也存在諸多限制因素。主要因素是麻醉劑嚴格的監管要求，這通常會導致核准流程延長，並給生產商帶來高昂的合規成本。

Propofol濫用和非法轉移的潛在風險，在一些備受矚目的案例中凸顯出來，導致各地監管機構對其審查力度加大，並將其列為管制藥品，進一步阻礙了其市場准入。此外，由於需要特定的儲存條件和熟練的給藥技術，丙泊酚在資源匱乏地區的應用也受到限制。儘管面臨這些挑戰，Propofol快速恢復的特性使其在不斷成長的門診手術市場中具有顯著優勢，蘊藏著巨大的發展機會。開發新型製劑，例如無脂製劑和穩定製劑，將帶來盈利的成長機會。此外，開發中國家醫療保健意識的提高、醫療旅遊的蓬勃發展以及微創手術的日益普及，也為全球Propofol注射劑的生產商和經銷商創造了巨大的市場機會。

本次調查的主要特點

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
• 本研究根據以下參數對全球Propofol注射市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
• 透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
• 這份全球Propofol注射市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
• 透過分析全球Propofol注射市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
• 促進因素
• 抑制因子
• 機會
• 影響分析
• 主要進展
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景
• 產業趨勢

第4章 全球Propofol注射劑市場：依產品類型分類，2021-2033年

• 非專利的
• 品牌

第5章 全球Propofol注射劑市場：依應用領域分類，2021-2033年

• 短期鎮靜（手術過程中的鎮靜）
• 長期鎮靜（加護病房- ICU）
• 麻醉誘導和維持

第6章 全球Propofol注射劑市場：依劑型分類，2021-2033年

• 單劑量管瓶
• 多管瓶小瓶
• 預填充式注射器

第7章 全球Propofol注射劑市場：依最終用戶分類，2021-2033年

• 醫院
• 門診手術中心（ASC）
• 診所
• 其他（例如，復健中心）

第8章 全球Propofol注射劑市場：依通路分類，2021-2033年

• 醫院藥房
• 零售藥房
• 網路藥房

第9章 全球Propofol注射劑市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第10章 競爭格局

• Fresenius Kabi
• Baxter International
• Braun Melsungen AG
• AbbVie Inc.
• Pfizer Inc.
• Hikma Pharmaceuticals
• Teva Pharmaceutical Industries Ltd.
• Sandoz（a Novartis division）
• Reddy's Laboratories
• Guangdong Jiabo Pharmaceutical
• Xian Libang Pharmaceutical
• Jiangsu Nhwa Pharmaceutical
• Sinopharm Guorui Pharmaceutical
• Midas Pharma
• Emcure Pharmaceuticals

第11章 分析師建議

• 機會分析
• 分析師意見
• Coherent Opportunity Map

第12章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

Propofol Injection Market is estimated to be valued at USD 1.77 Bn in 2026 and is expected to reach USD 3.35 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.5% from 2026 to 2033.

The global propofol injection market represents a critical segment within the pharmaceutical industry, encompassing one of the most widely utilized intravenous anesthetic agents in modern medical practice. Propofol, chemically known as 2,6-diisopropylphenol, serves as a short-acting sedative-hypnotic agent primarily employed for induction and maintenance of general anesthesia, as well as sedation in intensive care units and procedural settings. This injectable formulation has revolutionized anesthetic practices globally due to its rapid onset, controllable depth of sedation, and swift recovery profile with minimal residual effects.

The market encompasses various concentrations and formulations of propofol injections, catering to diverse medical applications including surgical procedures, diagnostic interventions, and critical care management. Healthcare institutions, including hospitals, ambulatory surgical centers, and specialty clinics, constitute the primary end-users driving market demand. The increasing prevalence of surgical procedures, growing geriatric population requiring medical interventions, and expanding outpatient surgical facilities significantly contribute to market expansion. Additionally, the rising adoption of propofol in emerging markets, coupled with continuous research and development initiatives for improved formulations, positions this market as a vital component of the global anesthesia pharmaceutical landscape.

Market Dynamics

The global propofol injection market is propelled by several compelling drivers, with the foremost being the exponential increase in surgical procedures worldwide, driven by an aging population requiring various medical interventions, from routine surgeries to complex operations. The growing prevalence of chronic diseases necessitating surgical treatments, coupled with rising healthcare expenditure and improved healthcare infrastructure in emerging economies, significantly boosts the market demand. Additionally, the preference for propofol over traditional anesthetic agents due to its superior pharmacokinetic properties, including rapid onset and recovery, minimal side effects, and excellent patient tolerance, drives adoption across healthcare facilities. However, the market faces notable restraints, primarily centered around stringent regulatory requirements for anesthetic drugs, which often result in lengthy approval processes and substantial compliance costs for manufacturers.

The potential for abuse and diversion of propofol, highlighted by high-profile cases, has led to increased regulatory scrutiny and controlled substance scheduling in various jurisdictions, creating additional barriers for market accessibility. Furthermore, the requirement for specialized storage conditions and skilled administration limits its usage in resource-constrained settings. Despite these challenges, significant opportunities emerge from the expanding outpatient surgical procedures market, where propofol's rapid recovery profile is particularly advantageous. The development of novel formulations, including lipid-free alternatives and enhanced stability versions, presents lucrative growth prospects. Additionally, increasing healthcare awareness in developing nations, expanding medical tourism, and the growing trend toward minimally invasive procedures create substantial market opportunities for propofol injection manufacturers and distributors globally.

Key Features of the Study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global propofol injection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include leading Fresenius Kabi, Baxter International, B. Braun Melsungen AG, AbbVie Inc., Pfizer Inc., Hikma Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Sandoz (a Novartis division), Dr. Reddy's Laboratories, Guangdong Jiabo Pharmaceutical, Xian Libang Pharmaceutical, Jiangsu Nhwa Pharmaceutical, Sinopharm Guorui Pharmaceutical, Midas Pharma, and Emcure Pharmaceuticals
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global propofol injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global propofol injection market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2021 - 2033)
• Generic
• Branded
• Application Insights (Revenue, USD Bn, 2021 - 2033)
• Short-term Sedation (Procedural Sedation)
  • Endoscopy (Colonoscopy, Upper GI Endoscopy)
  • Bronchoscopy
  • Cardioversion
  • Minor Surgical Procedures
• Long-term Sedation (Intensive Care Unit - ICU)
• Induction and Maintenance of Anesthesia
• Formulation Insights (Revenue, USD Bn, 2021 - 2033)
• Single-Dose Vials
• Multi-Dose Vials
• Pre-filled Syringes
• End User Insights (Revenue, USD Bn, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Clinics
• Others (e.g., Recovery Centers)
• Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Fresenius Kabi
• Baxter International
• Braun Melsungen AG
• AbbVie Inc.
• Pfizer Inc.
• Hikma Pharmaceuticals
• Teva Pharmaceutical Industries Ltd.
• Sandoz (a Novartis division)
• Reddy's Laboratories
• Guangdong Jiabo Pharmaceutical
• Xian Libang Pharmaceutical
• Jiangsu Nhwa Pharmaceutical
• Sinopharm Guorui Pharmaceutical
• Midas Pharma
• Emcure Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Propofol Injection Market, By Product Type
  • Global Propofol Injection Market, By Application
  • Global Propofol Injection Market, By Formulation
  • Global Propofol Injection Market, By End User
  • Global Propofol Injection Market, By Distribution Channel
  • Global Propofol Injection Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Propofol Injection Market, By Product Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Generic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Branded
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Propofol Injection Market, By Application, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Short-term Sedation (Procedural Sedation)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Endoscopy (Colonoscopy, Upper GI Endoscopy)
    • Bronchoscopy
    • Cardioversion
    • Minor Surgical Procedures
• Long-term Sedation (Intensive Care Unit - ICU)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Induction and Maintenance of Anesthesia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Propofol Injection Market, By Formulation, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Single-Dose Vials
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Multi-Dose Vials
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Pre-filled Syringes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Propofol Injection Market, By End User, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Ambulatory Surgical Centers (ASCs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others (e.g., Recovery Centers)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Propofol Injection Market, By Distribution Channel, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Propofol Injection Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Fresenius Kabi
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Baxter International
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Braun Melsungen AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AbbVie Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hikma Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sandoz (a Novartis division)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Reddy's Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Guangdong Jiabo Pharmaceutical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Xian Libang Pharmaceutical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Jiangsu Nhwa Pharmaceutical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sinopharm Guorui Pharmaceutical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Midas Pharma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Emcure Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us